GA31   Click here for help

GtoPdb Ligand ID: 14580

Immunopharmacology Ligand
Compound class: Peptide
Comment: GA31 is a 31‐mer methionine‐sulfoxidized peptide that is designed to block TREM1-mediated pro-inflammatory signalling [5]. It contains an N-terminal domain comprising human TREM‐1 213‐221 (GF9), plus a chain representing human apo A‐I helix 4 (apo A‐I 123‐144). GA31 was designed using a drug discovery platform termed signaling chain homooligomerization (or "SCHOOL"), which produces receptor-specific peptides that disrupt protein-protein interactions and immunomodulatory signalling by target receptors via a ligand independent mechanism [6]. For targeted intracellular delivery to macrophages, GA31 is formulated with a macrophage-specific lipopeptide complex (GA31-LPC).
No information available.
Summary of Clinical Use Click here for help
GA31-LPC was granted FDA orphan designation in March 2026, as a treatment for retinopathy of prematurity [1].